本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Tyra Biosciences, Inc.

25.73
+1.305.32%
盤後25.730.00000.00%19:34 EDT
成交量:206.97萬
成交額:5,286.27萬
市值:17.69億
市盈率:-10.71
高:25.88
開:24.58
低:24.40
收:24.43
52周最高:40.65
52周最低:12.38
股本:6,875.59萬
流通股本:4,433.30萬
量比:1.62
換手率:4.67%
股息:- -
股息率:- -
每股收益(TTM):-2.4031
每股收益(LYR):-2.0125
淨資產收益率:-45.31%
總資產收益率:-28.46%
市淨率:5.00
市盈率(LYR):-12.79

資料載入中...

2022/03/03

重要事件披露

8-K - Current report
2022/02/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/03

重要事件披露

8-K - Current report
2021/11/03

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/09/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/09/27

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/09/27

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/09/27

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/09/24

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/09/21

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/09/17

重要事件披露

8-K - Current report
2021/09/15

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/09/14

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/09/10

SEC問詢函

CORRESP [Cover] - Correspondence
2021/09/10

SEC問詢函

CORRESP [Cover] - Correspondence
2021/09/09

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/08/20

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/08/20

SEC問詢函

CORRESP [Cover] - Correspondence
2021/08/20

SEC問詢函

CORRESP [Cover] - Correspondence